Comparison of treatment modalities for inpatient asthma exacerbations among US pediatric hospitals

J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):855-857.e1. doi: 10.1016/j.jaip.2016.10.004. Epub 2016 Nov 23.

Abstract

When comparing treatment for inpatient pediatric asthma hospitalizations, there is significant variability in treatment with magnesium sulfate, ipratropium bromide, terbutaline, heliox, BiPAP, and mechanical ventilation for PICU admissions across U.S. pediatric hospitals.

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Adrenergic beta-2 Receptor Agonists / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / mortality
  • Bronchodilator Agents / therapeutic use*
  • Child
  • Critical Care
  • Disease Progression
  • Female
  • Hospitals, Pediatric*
  • Humans
  • Inpatients
  • Ipratropium / therapeutic use
  • Male
  • Practice Guidelines as Topic
  • Survival Analysis
  • United States

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Ipratropium